Moody Aldrich Partners’s Viridian Therapeutics VRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$1.25M Buy
2025
Q1
$780K Sell
2024
Q4
$1.13M Buy
2023
Q3
Sell
2023
Q2
$1.37M Sell
2023
Q1
$2.53M Buy
2022
Q4
$1.72M Buy